Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA)
CUSIP: 92511W108
Q2 2019 13F Holders as of 30 Jun 2019
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Shares outstanding
- 92,448,158
- Total 13F shares
- 9,017,971
- Share change
- +202,136
- Total reported value
- $104,753,394
- Price per share
- $11.62
- Number of holders
- 40
- Value change
- +$2,578,213
- Number of buys
- 23
- Number of sells
- 8
Quarterly Holders Quick Answers
What is CUSIP 92511W108?
CUSIP 92511W108 identifies VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 92511W108:
Top shareholders of VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
3.7%
|
3,410,412
|
$38,537,000 | — | 31 Mar 2019 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.6%
|
1,479,733
|
$15,996,000 | — | 31 Mar 2019 | |
| Fosun International Ltd |
13F
|
Company |
0.86%
|
794,279
|
$8,586,000 | — | 31 Mar 2019 | |
| FMR LLC |
13F
|
Company |
0.67%
|
621,800
|
$6,722,000 | — | 31 Mar 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.52%
|
483,762
|
$5,230,000 | — | 31 Mar 2019 | |
| KORNITZER CAPITAL MANAGEMENT INC /KS |
13F
|
Company |
0.48%
|
447,341
|
$4,836,000 | — | 31 Mar 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.47%
|
431,245
|
$4,661,000 | — | 31 Mar 2019 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.25%
|
234,116
|
$2,531,000 | — | 31 Mar 2019 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.16%
|
147,267
|
$1,592,000 | — | 31 Mar 2019 | |
| CONNING INC. |
13F
|
Company |
0.14%
|
129,013
|
$1,395,000 | — | 31 Mar 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.12%
|
107,212
|
$1,159,000 | — | 31 Mar 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.09%
|
85,190
|
$921,000 | — | 31 Mar 2019 | |
| STATE STREET CORP |
13F
|
Company |
0.09%
|
84,880
|
$918,000 | — | 31 Mar 2019 | |
| Asymmetry Capital Management, L.P. |
13F
|
Company |
0.08%
|
70,458
|
$762,000 | — | 31 Mar 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.07%
|
61,583
|
$665,000 | — | 31 Mar 2019 | |
| ESSEX INVESTMENT MANAGEMENT CO LLC |
13F
|
Company |
0.06%
|
51,673
|
$559,000 | — | 31 Mar 2019 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
26,291
|
$284,000 | — | 31 Mar 2019 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.03%
|
26,083
|
$282,000 | — | 31 Mar 2019 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.03%
|
25,410
|
$275,000 | — | 31 Mar 2019 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
16,668
|
$180,000 | — | 31 Mar 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
13,455
|
$144,000 | — | 31 Mar 2019 | |
| Capital Investment Advisory Services, LLC |
13F
|
Company |
0.01%
|
12,400
|
$134,000 | — | 31 Mar 2019 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.01%
|
10,250
|
$111,000 | — | 31 Mar 2019 | |
| BECK MACK & OLIVER LLC |
13F
|
Company |
0.01%
|
10,000
|
$108,000 | — | 31 Mar 2019 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
6,861
|
$74,000 | — | 31 Mar 2019 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
4,568
|
$50,000 | — | 31 Mar 2019 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0%
|
3,400
|
$37,000 | — | 31 Mar 2019 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
2,967
|
$32,000 | — | 31 Mar 2019 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
2,874
|
$31,000 | — | 31 Mar 2019 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
2,614
|
$28,000 | — | 31 Mar 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
2,328
|
$25,000 | — | 31 Mar 2019 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
2,261
|
$24,441 | — | 31 Mar 2019 | |
| UBS Group AG |
13F
|
Company |
0%
|
2,152
|
$24,000 | — | 31 Mar 2019 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
1,886
|
$20,000 | — | 31 Mar 2019 | |
| STRS OHIO |
13F
|
Company |
0%
|
1,700
|
$18,000 | — | 31 Mar 2019 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
1,115
|
$12,000 | — | 31 Mar 2019 | |
| Squar Milner Financial Services LLC |
13F
|
Company |
0%
|
1,005
|
$10,000 | — | 31 Mar 2019 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
300
|
$3,000 | — | 31 Mar 2019 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
252
|
$3,000 | — | 31 Mar 2019 | |
| LADENBURG THALMANN FINANCIAL SERVICES INC. |
13F
|
Company |
0%
|
115
|
$1,000 | — | 31 Mar 2019 |
Institutional Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q2 2019
As of 30 Jun 2019,
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,017,971 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, ORBIMED ADVISORS LLC, Fosun International Ltd, BlackRock Inc., FMR LLC, KORNITZER CAPITAL MANAGEMENT INC /KS, VANGUARD GROUP INC, STATE STREET CORP, Point72 Asset Management, L.P., and Asymmetry Capital Management, L.P..
This page lists
40
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2019 vs Q1 2019 Across Filers
Q1 2019 holders
40
Q2 2019 holders
40
Holder diff
0
| Investor | Q1 2019 Shares | Q2 2019 Shares | Share Diff | Share Chg % | Q1 2019 Value $ | Q2 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.